We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Real-Time Apneic Screening Device

By Biotechdaily staff writers
Posted on 12 Jan 2007
Print article
A small, easy-to-use, and unobtrusive device allows screening for apneic events in persons who may be suspected of having obstructive sleep apnea (OSA).

The battery-powered RUSleeping real time screening (RTS) device consists of a base unit and a nasal cannula. Respiratory airflow pressure is sensed via the cannula and the device starts to record apneic events. When breathing decreases by 50% or more for 10 seconds or longer, it is considered an apneic event and is recorded on the liquid crystal display (LCD) readout. The device is convenient to operate and can be re-used. No accessory equipment, software, or electrical outlet is needed.

Based upon a patient's at-home overnight score, physicians can interpret if the patient is a likely candidate for an immediate polysomnogram (PSG). Sleep lab physicians can provide the RUSleeping RTS to patients to pre-screen at home for OSA before the patient is seen for an in-lab PSG. By being presented with objective data regarding their apneic events, patients may more readily accept the need for a complete PSG and consequent treatment, if needed. The RUSleeping RTS is manufactured by Respironics (Murrysville, PA, USA).

"The RUSleeping RTS device is much less cumbersome and expensive than many other screening devices. It is a quick and simple tool for busy clinicians who have patients presenting with subjective symptoms of OSA,” said Respironics product manager Rick Herrle. "This may help bring patients one step closer to diagnosis and treatment, which is what good patient outcomes are all about.”



Related Links:
Respironics
Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.